“…In the same pursuit, Biosensors Nanotechnology provides detailed review chapters on a range of nanostructures such as nanoparticles, nanowires, nanotubes, nanoribbons, nanorods, nanobelts and nanosheets in the construction of biosensors with set applications of biosensors nanotechnology for biological and chemical analyses, food safety industry, biomedical diagnostics, clinical detection, and environmental monitoring. The senior contributors write on the following topics: ZnO and graphene microelectrode applications in biosensing Assembly of polymers/metal nanoparticles Gold nanoparticle-based electrochemical biosensors Impedimetric DNA sensing employing nanomaterials Graphene and carbon nanotube based biosensors The-state-of-art of nanomedicine Computational nanochemistry study BFPF green fluorescent protein chromophore Biosynthesis of metal nanoparticles Ionic discotic liquid crystals Role of advanced materials as nanosensors in water treatment Bioconjugated-nanoporous gold films in electrochemical biosensors Combination of molecular imprinting and nanotechnology Recent development of fiber reinforced composite materials Principal and properties of multiferroics and ceramics…”

“…In Hospital Operations , two leading operations management experts and four senior physicians demonstrate how to apply new OM advances to substantially improve any hospital’s operational, clinical, and financial performance. Replete with examples, this bookshows how to diagram hospital flows, trace interconnections, and optimize flows for better performance. …”

“…Each bimonthly issue features 4-6 educational review articles focused on a special issue and 10-20 original articles, pictorial essays, special reports, case reports, and letters to the editor, all of which encompass clinical and technical investigations, and health policies in radiology. …”

“…This perspective began to change in the early 1990s due to seminal publications from the Adventist Health Study, which showed that nut consumption significantly improved heart health-related outcomes. Many randomized clinical trials, epidemiological studies, and in vitro/in vivo mechanistic studies have since explored the role of eating nuts and its relation to health. …”

“…This Special Issue of the Journal of Clinical Medicine will cover the following important aspects of miRNA functions in cancer biology: Biosynthesis of miRNA and its roles in gene regulation; Roles of miRNA in cancer biology, including 1 Roles of miRNA in tumor initiation and development, 2 Roles of miRNA in drug resistance, 3 Roles of miRNA in metastasis; Therapeutic potential of miRNAs for cancer therapy; Roles of circulating miRNAs in cancer development; Expression levels/profiles of body fluid miRNAs for cancer diagnosis, prognosis, and therapeutic responses; Novel and efficient miRNA delivery methods and their applications in cancer therapy…”

“…The analysis assumes that clinical outcomes for the patients would be the same irrespective of being diagnosed using CT or the new alternative, S100B and selected CT. …”

“…The magnitude of the clinical effect is uncertain. 2. There are no studies comparing LVAD with heart transplantation. 3. …”

“…Several groups of drugs have shown in clinical trials to prevent CVD. In this report, we have evaluated the cost-effectiveness of these drugs. …”

“…Methods We developed a health economic model of the Markov type in which we compared data from a clinical study, Miller et al . 2007, with Norwegian cost data associated with the treatment alternatives. …”

“…The national groups of experts defined the relevant conditions by clinical criteria and not linked to ICD-10 codes (ICD = International Codes of Diseases). …”

“…Background Health clinics and school health is a statutory service in Norway. …”

“…Most primary studies were conducted in the US primary health-care system, often in Health Maintenance Organizations (HMOs) or at university clinics. We did not find any Norwegian or Nordic effect studies which satisfied our inclusion criteria. …”

“…A combined analysis from 2009 of two Norwegian randomized controlled clinical trials, with extended post-trial follow-up, demonstrated however, an increased incidence of cancer among patients taking folic acid for homocysteine reduction as secondary prevention of cardiovascular events. …”

“…To design and test a model for improving PCOR engagement and data integration between patient-centered registry self-reported data and health plan administrative claims data, we developed privacy-preserving record linkage (PPRL) methods to determine overlapping membership in the National Patient-Centered Clinical Research Network (PCORnet), patient-powered research networks (PPRNs), and a health plan research network (HPRN). …”

“…LIMITATIONS AND SUBPOPULATION CONSIDERATIONS: Most participants in the SSC arm (96%) were willing to set a quit date; findings might be different in actual clinical practice, which might include more smokers not interested in quitting in the immediate future. …”

“…OBJECTIVES: We conducted a randomized clinical trial to test the effectiveness of face-to-face (FTF) and online mentoring by trained peers, compared with usual care, on CKD patients' QOL, patient activation, and caregiver burden. …”

“…We hypothesized that this technology-enabled communication feedback tool would improve patient quality of life by promoting clinically appropriate treatment changes. METHODS: Using a cluster (physician level) randomized controlled trial design, we randomized 1834 primary care physicians to the treatment or control condition (usual care plus brief, noninteractive educational telephone message), screened 2203 patients newly treated for DPN symptoms by these providers and recruited 1270 patients (83% of eligible patients) to participate in the intervention. …”

“…Some of these social changes include multiculturalism and its associated diversity of values; the transition to the digital era with its new demands on confidentiality, clinical boundaries, and privacy; the empowerment of psychiatric service users as full participants and co-producers of care; the development of new technologies of assessment and treatment, varying in their invasiveness and risk; the recognition of expanded social roles for psychiatrists, and the associated virtues of psychiatric citizenship; and the development of new practice models, settings, participants, and oversight, all of which represent profound challenges and opportunities for the ethical practice of psychiatry. …”